Pune, India, March 2021, MRFR Press Release/- Market Research Future has published a Cooked Research Report on the Global Sleep Apnea Device Market.
Global Sleep Apnea Device Market is expected to have a market value of USD 7,683.72 Million by 2027.
In sleep apnea, a person's breathing is interrupted in sleep. Untreated sleep apnea can cause chronic disorders, such as high blood pressure, cardiovascular diseases, obesity, and neurological conditions.
Global Sleep Apnea Device Market has been segmented into Type and End User. The global sleep apnea device market, by type, has been segmented into therapeutic and diagnostic device. Based on therapeutic device, the market has been segmented into positive airway pressure devices, facial interfaces, accessories, oral appliances, adaptive servo-ventilators, surgical devices. Positive airway pressure devices is further classified as automatic positive airway pressure devices, bilevel positive airway pressure devices and continuous positive airway pressure devices. The facial interface type is further segmented into full-face masks, nasal pillow masks, and nasal masks. The accessories type is classified as humidifier accessories, power accessories, transportation accessories, communication accessories, and chin restraints. Oral appliances type is further categorized into mandibular advancement devices and tongue-retaining devices. By diagnostic device type, it is segmented as polysomnography devices, home sleep testing devices, pulse oximeters, and sleep screening devices. The market for the global sleep apnea device market, by end user, is bifurcated into home care settings, sleep laboratories, and others.
Global Sleep Apnea Device Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and Middle East & Africa.
The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The Americas led the market and accounted for the largest share in 2019 due to a well-established healthcare system, rising number of patients with lung disease, and technological advancements in sleep apnea devices.
The European sleep apnea device market has been further segmented into Western Europe and Eastern Europe. The Western Europe Sleep Apnea Device market has further been classified into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The presence of a vast patient pool in European countries and the number of market players involved in product launch and approval is expected to propel the demand for sleep apnea devices during the forecast period, thus fueling the market growth in the European region.
The sleep apnea device market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is expected to register the highest growth rate over the forecast period from 2020 to 2027. In addition, the rising pool of patients with respiratory diseases and technological advancements is expected to contribute to the growth of the market in Asia-Pacific countries.
The Middle East & Africa sleep apnea device market is segmented into the Middle East and Africa. The increasing number of smokers and other patient populations suffering from lung disease in the region is expected to fuel the market growth of the region.
Access Report Details @ https://www.marketresearchfuture.com/reports/sleep-apnea-devices-market-2061
MRFR recognizes the following companies as the Key Players in the global Sleep Apnea Device Market— Koninklijke Philips (Netherlands), ResMed (US), LivaNova (UK), Compumedics (Australia), Nihon Kohden (Japan), GE Healthcare (US), Natus Medica (US), BMC Medical (China), Cadwell (US), and Curative Medical (US).
Key Findings of the Study